Clinical Trial Update: Irinotecan, Gemcitabine and Radiation Therapy for Pancreatic Cancer [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial evaluated the combination of irinotecan and gemcitabine with radiation therapy for pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Pancreatic Cancer | Phase 2, Phase 3 | Status: COMPLETED